EGFR and escherichia coli infection: These findings indicate that pharmacological inhibition and dominant-negative expression of EGFR did not interfere with SphK2 activation by meningitic E. coli. Next, we examined and compared the EGFR activation upon E. coli infection in HBMEC, with and without inhibition of S1P function.